Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTH versus compound betamethasone for acute gouty arthritis
ChiCTR2100041745Phase 4Completed
- Sponsor
- Huashan Hospital
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in gout and acute gout flare comparing ACTH Group with Compound betamethasone group (2 arms). Primary endpoint: Proportion of patients achieving 50% reduction in target-joint pain at 72 hours. Started Apr 2021; status: completed.
02
Drugs
repository corticotropin injectionbetamethasone
03
Conditions
goutacute gout flare
Beyond the preview
Go deeper on ChiCTR2100041745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041745.